Coats plus is a highly pleiotropic disorder particularly affecting the eye, brain, bone and gastrointestinal tract. Here, we show that Coats plus results from mutations in CTC1, encoding conserved telomere maintenance component 1, a member of the mammalian homolog of the yeast heterotrimeric CST telomeric capping complex. Consistent with the observation of shortened telomeres in an Arabidopsis CTC1 mutant and the phenotypic overlap of Coats plus with the telomeric maintenance disorders comprising dyskeratosis congenita, we observed shortened telomeres in three individuals with Coats plus and an increase in spontaneous gH2AX-positive cells in cell lines derived from two affected individuals. CTC1 is also a subunit of the a-accessory factor (AAF) complex, stimulating the activity of DNA polymerase-a primase, the only enzyme known to initiate DNA replication in eukaryotic cells. Thus, CTC1 may have a function in DNA metabolism that is necessary for but not specific to telomeric integrity.
Telomeres comprise long TTAGGG nucleotide repeats and associated proteins located at the ends of chromosomes. Telomeres both protect the chromosome terminus from unwanted nuclease and DNA repair activities and provide a mechanism to compensate for the inability of DNA polymerase to replicate the 5′ end of a linear chromosome. Telomeric DNA is packaged by a core group of proteins that bind the DNA duplex and the 3′ G overhang on the chromosome terminus. The associated telomere proteins form a protective cap that pre vents the chromosome end from eliciting a DNA damage response.
Although it is essential to sequester the DNA end from nuclease and DNA repair activities for much of the cell cycle, during S phase the telomere must be made accessible to telomerase and the DNA replication machinery 1 .
The bone marrow failure syndrome dyskeratosis congenita repre sents a clinically and genetically heterogeneous collection of pheno types arising from telomeric protein dysfunction. Dyskeratosis congenita-associated mutations have been identified in the genes encoding DKC1, TERC, TERT, NOP10, NHP2 and TCAB1, which belong to the telomerase holoenzyme responsible for maintaining telomere length, and a member of the shelterin protein complex TINF2, which is responsible for maintaining the structural integrity of the telomere. Thus, dyskeratosis congenita is a disorder of telomere maintenance and is associated with shortened telomeres 2, 3 .
Coats plus is a rare disorder of which the most characteristic features are retinal telangiectasia and exudates (Coats disease), a distinctive pattern of intracranial calcification with an associated leukodystrophy and brain cysts, osteopenia with a tendency to frac tures and poor bone healing, and a high risk of lifelimiting gastro intestinal bleeding and portal hypertension caused by the development of vasculature ectasias in the stomach, small intestine and liver [4] [5] [6] [7] [8] [9] ( Fig. 1) . These extraneurological problems differentiate Coats plus from Labrune syndrome (leukoencephalopathy with calcifications and cysts), in which affected individuals otherwise show an identical neuroradiological appearance 10 . Of note, some individuals with Coats plus develop sparse, graying hair, dystrophic nails and a normocytic anemia that might reflect a degree of bone marrow failure. These latter Mutations in CTC1, encoding conserved telomere maintenance component 1, cause Coats plus features are also observed in dyskeratosis congenita. Furthermore, individuals with HoyeraalHreidarsson or Revesz syndrome, both of which are associated with telomeric shortening, can have intracranial calcification and, in the case of Revesz syndrome, an exudative retinopathy 2 .
In view of reports of both male and female affected siblings, we considered it most probable that Coats plus was an autosomal reces sive trait, although we noted that our collection of ten families fulfill ing strict diagnostic criteria (characteristic intracranial calcification with white matter changes, exudative retinopathy with telangiectasia and fractures with poor bone healing and/or gastrointestinal vas cular ectasia) included only one family in which the parents were known to be related. Because we were unable to define a disease associated locus using SNP arrays (data not shown), we undertook wholeexome sequencing of two siblings (F335_P1 and F335_P2) and two additional unrelated individuals (F332 and F336) showing classical features of Coats plus (Supplementary Table 1 ). We per formed wholeexome capture followed by massively parallel sequenc ing. Over 4.8 Gb of sequence was generated for each subject, such that >76% of the coding bases of the GENCODEdefined exome were represented by at least ten reads (Supplementary Table 2 ). We identified singlenucleotide substitutions and small insertion and/or deletion variants using our inhouse variant calling pipe line. We analyzed the exome variant profiles under a model of a rare autosomal recessive disorder. Taking into account difficulties in identifying insertion and deletion variants, we looked for genes harboring at least one previously unobserved nonsynonymous or splicesite substitution or a coding insertion or deletion in the same gene in all four individuals, with the same variant(s) required in the siblings examined. CTC1 (encoding conserved telomere maintenance component 1) was highlighted as the only candi date gene when using this strategy. Sanger sequencing confirmed the variants in these affected individuals, and all parents tested showed appropriate heterozygosity for a single variant. In light of these data, we proceeded to sequence an additional nine affected individuals from seven families showing typical disease characteristics.
We identified biallelic CTC1 variants that were likely to be path ogenic in the affected proband(s) from nine of the ten families with Coats plus that were sequenced ( Table 1) . We also identified two CTC1 variants in a Norwegian individual (F319) having exu dative retinopathy with a history of recurrent fractures but in whom cranial imaging had not been undertaken (and who there fore did not fulfill our initial inclusion criteria). In only one family with a prior clinical assignment of Coats plus were we unable to identify CTC1 variants. In the ten families with presumed biallelic mutations, six harbored a nonsense lesion in combination with a missense variant, while the consequences of the splicesite vari ant seen in F273 and the inframe deletions observed in F367 and F382 are currently unknown. The probands from F342 carried two missense variants (c.775G>A and c.2518C>T). Of the 14 distinct l e t t e r s mutations observed, three were seen in more than one family (c.724_727del, four families; c.2954_2956del, two families; c.2959C>T, three families) ( Table 1) .
Reflecting apparently rapid evolutionary divergence, some telomeric proteins show poor interspecies conservation 11 . The human CTC1 protein sequence shares only 69% iden tity with mouse, 30% with zebrafish and 14% with Arabidopsis. Not unexpectedly, although the residues affected by nonsynonymous missense changes are well conserved across mammals, ClustalW alignment showed a relatively low level of residue conservation in other species (Supplementary Fig. 1 ). Related to this, 15 of the 20 CTC1 mutations we observed occurred in one of four exons (Fig. 2) . However, although we suspect that this clustering is of func tional significance, it is difficult to model the domain structure of CTC1 because of the high degree of sequence divergence from other proteins 12 . Of note, none of the 14 distinct, putatively pathogenic CTC1 variants have been annotated as polymorphisms in dbSNP. Moreover, 13 of these variants were not seen in 1,730 European American and AfricanAmerican subjects collated in the Exome Variant Server database, and the c.19C>T transition seen in F340 was recorded in only 1 of 1,497 EuropeanAmericans (the same ancestral background as the affected proband).
Cerebroretinal microangiopathy with calcifications and cysts (CRMCC) is a term coined to encompass the Coats plus and Labrune syndrome phenotypes, on the grounds that the neuro radiological characteristics of these two disorders are essentially identical 7, 8 . Thus, we sequenced CTC1 in a collection of probands from 21 families showing stereotypical intracranial calcification and white matter changes in the absence of extraneurological fea tures, but we were unable to identify any likely pathogenic variants (Supplementary Table 3) .
Recently, it has been shown that CTC1 interacts with STN1 and TEN1 to form the mammalian homolog of the yeast hetero trimeric Cdc13Stn1Ten1 (CST) telomeric capping complex 13, 14 . Consequently, we also undertook Sanger sequencing of OBFC1 (STN1) and TEN1 in our collection of individuals with Labrune syndrome and in the proband with Coats plus in whom we identified no CTC1 mutations. Again, sequencing identified no variants of likely pathogenic significance (Supplementary Tables 3 and 4) .
In view of the finding of shortened telomeres in an Arabidopsis CTC1 mutant 13 and the phenotypic overlap between Coats plus and the telomeric maintenance disorders comprising dyskeratosis con genita, we measured telomere lengths 15 in F332, F367 and F382 at the ages of 20, 20 and 3 years, respectively. Samples were also available from the mother and heterozygous brother of F367 and from both parents of F332 and F382. Testing showed markedly shortened telo meres in lymphocytes and granulocytes from the peripheral blood of F367 and F382 and telomeric lengths at the lower range of normal in the heterozygous relatives of these individuals (Fig. 3) . In F332, telomere length was recorded on the first percentile for age in both lymphocytes and granulocytes, with parental telomere lengths also at the lower range of normal.
Considering the enrichment for CTC1 variants in individuals with a predefined clinical and radiological diagnosis, we are confi dent that mutations in CTC1 represent the major cause of Coats plus. The observation of a single family, F339, in whom we were unable to identify mutations suggests possible genetic heterogeneity or a pheno copy. Of note, the parents of this child are related as third cousins, but there was no evidence of homozygosity around any of the three CST protein-encoding genes (data not shown).
Although Coats plus is rare and inherited as an autosomal recessive trait, none of the ten mutationpositive families we identified are con sanguineous. In keeping with this, all of the affected individuals in these families are compound heterozygotes for two different CTC1 variants (with six of ten families harboring a nonsense and missense mutation in combination). This observation helps to explain our inability to define a disease locus using autozygosity mapping and leads us to speculate that biallelic null mutations might be incompatible with development, whereas homozygosity for (most) missense variants may be associated with a normal phenotype or a different pathogenic one.
We and others have noted the highly stereotyped neuroradiological features common to Coats plus and Labrune syndrome, leading to the introduction of the umbrella term CRMCC. However, a recent analysis of our cohort (data not shown) suggested that the two groups might be dis tinguished according to the presence or absence of extraneurological fea tures, as, in our experience, individuals without retinal abnormalities have never shown any skeletal or gastrointestinal manifestations over extended time periods. The genetic data presented here support this conclusion, indicating that Coats plus and Labrune syndrome are not allelic.
CTC1 comprises 23 exons and encodes a 134.5kDa protein. Because of rapid evolutionary divergence, the human CST complex was only defined recently 13, 14 . This led to the recognition that mammalian l e t t e r s CTC1 is identical to one subunit of αaccessory factor (AAF132), whereas a second subunit of AAF (AAF44, also known as OBFC1) corresponds to mammalian STN1 (ref. 16 ).
The AAF complex stimulates the activity of DNA polymeraseα primase, the only enzyme known to initiate DNA replication in eukaryotic cells 17 . AAF functions by binding singlestranded DNA (ssDNA) and enhancing DNA polymeraseα primase association with a DNA template. The finding that human CTC1STN1 modulates DNA polymeraseα primase activity indicates that, as for budding yeast CST, mammalian CTC1STN1 provides a link to the lagging strand replication machinery. Thus, it can be proposed that a con served function of CST is to promote efficient priming of telomeric Cstrand synthesis. In addition, given the role of Cdc13 in budding yeast, another conserved function of the CST complex could be to regulate telomerase. All of these processes may contribute to main taining telomeric DNA integrity and could couple the conventional replication process to telomerespecific priming and telomerase dependent elongation steps 18 (see Supplementary Fig. 2) .
Experiments in budding yeast and Arabidopsis have identified a functional role for the CST complex in maintaining telomeric structural integrity, and our finding of shortened telomeres in individuals with CTC1 mutations confirms an important role for the CST complex in mammalian telomere metabolism. However, the CST complex only partially localizes to telomeres and binds to ssDNA in a sequenceindependent manner (through the oligonucleotide/oligosaccharidebinding (OB) fold domains predicted to be present in all three subunits) 13, 14 . Of note, knockdown of CTC1 in human cells resulted in an increase in the number of γH2AX foci not confined to telomeres 13 . Although we did not study chromo somal localization, we observed a significant increase in spontaneous γH2AXpositive cells in cell lines from the two affected individuals (F332 and F382) that we were able to examine (P = 0.0001 and 0.0007, respec tively), indicative of an ongoing DNA damage response ( Supplementary  Fig. 3 ). Consequently, it is possible that the CST complex may have a more general role in DNA replication and repair that is frequently required by but not specific to telomeres.
Our interest in Coats plus and Labrune syndrome derives from ongoing research into disorders associated with the presence of intra cranial calcification. As such, our cohort is biased toward individuals with obvious neurological involvement. It is possible then that the phenotypic spectrum associated with CTC1 mutations may be broader than that presented here. Of note, phenotypic overlap with dyskeratosis congenita was appreciated at the time of the first clinical description of Coats plus, leading us to speculate that cohorts of indi viduals with a diagnosis of dyskeratosis congenita may be enriched for pathogenic variants in CTC1, OBFC1 (STN1) and/or TEN1.
URLs. National Heart, Lung, and Blood Institute (NHLBI) Exome Sequencing Project (ESP) Exome Variant Server, http://evs.gs.washington. edu/EVS/; SplicePort, http://spliceport.cs.umd.edu/; GENCODE, http://www.gencodegenes.org/; ClustalW, http://www.ebi.ac.uk/tools/ msa/clustalw2/; Primer3Plus, http://www.primer3plus.com/.
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Methods and any associated references are available in the online version of the paper at http://www.nature.com/naturegenetics/.
Accession codes. Nucleotide sequences are available from Entrez PubMed for human CTC1 (NM_025099.5), human OBFC1 (STN1) (NM_024928.4) and human TEN1 (NM_001113324.2), as is the human CTC1 protein sequence (NP_079375.3).
Note: Supplementary information is available on the Nature Genetics website. Telomere lengths were assessed in lymphocytes and granulocytes from F332, F367 and F382 at the ages of 20, 20 and 3 years, respectively, and from unaffected family members harboring a single CTC1 mutation. Telomere lengths were markedly shortened in two affected individuals (F367 and F382) and were at the lower range of normal in their heterozygous relatives. In F332, telomere length was recorded on the first percentile for age in both lymphocytes and granulocytes, with parental telomere lengths at the lower range of normal (being less than the first percentile in the father in granulocytes). The reference range for telomere length over age in percentiles was derived from telomere length analyses in lymphocytes and granulocytes from 400 healthy individuals.
